A systematic review on the effect of bevacizumab in exudative age-related macular degeneration: a response to a letter to the editor by Schmucker et al.

被引:0
|
作者
Schouten, Jan S. A. G. [1 ]
La Heij, Ellen C. [1 ]
Webers, Carroll A. B. [1 ]
Lundqvist, Igor J. [1 ]
Hendrikse, Fred [1 ]
机构
[1] Maastricht Univ Hosp, Dept Ophthalmol, NL-6202 AZ Maastricht, Netherlands
关键词
SAFETY;
D O I
10.1007/s00417-009-1244-x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:453 / 454
页数:2
相关论文
共 50 条
  • [31] RESVEGA in exudative age-related macular degeneration
    Kubicz, A.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [32] PREDICTING RESPONSE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION TO BEVACIZUMAB BASED ON SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY
    Segal, Ori
    Barayev, Edward
    Nemet, Arie Y.
    Mimouni, Michael
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (02): : 259 - 263
  • [33] Bilateral Intravitreal Bevacizumab Injection for Exudative Age-Related Macular Degeneration: Effect of Baseline Visual Acuity
    Jonas, Jost B.
    Tao, Yong
    Rensch, Florian
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 401 - 405
  • [34] Letter to the Editor: Preventing Progression in Nonexudative Age-Related Macular Degeneration With Subthreshold Laser Therapy: A Systematic Review
    Meizner, Daniela
    Lisker, Andres
    Marin, A. Itzam
    Quiroz-Mercado, Hugo
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (09): : 602 - 602
  • [35] RANIBIZUMAB AND BEVACIZUMAB FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION: A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION
    Martinez Ferez, I. M.
    Flores Moreno, S.
    VALUE IN HEALTH, 2011, 14 (07) : A503 - A504
  • [36] INTRAVITREAL BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH GOOD VISUAL ACUITY
    Axer-Siegel, Ruth
    Bor, Elite
    Bourla, Dan H.
    Weinberger, Dov
    Mimouni, Karin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1811 - 1820
  • [37] Microperimetric changes after intravitreal bevacizumab injection for exudative age-related macular degeneration
    Ozdemir, Hakan
    Karacorlu, Murat
    Senturk, Fevzi
    Karacorlu, Serra Arf
    Uysal, Omer
    ACTA OPHTHALMOLOGICA, 2012, 90 (01) : 71 - 75
  • [38] Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration
    Bidot, M. L.
    Malvitte, L.
    Bidot, S.
    Bron, A.
    Creuzot-Garcher, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2011, 34 (06): : 376 - 381
  • [39] Electrophysiological effects of intravitreal Avastin (bevacizumab) in the treatment of exudative age-related macular degeneration
    Karanjia, R.
    Eng, K. T.
    Gale, J.
    Sharma, S.
    ten Hove, M. W.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (09) : 1248 - 1252
  • [40] Intravitreal Bevacizumab Affects Retinal Oximetry in Patients with Exudative Age-related Macular Degeneration
    Traustadottir, Valgerdur Dora
    Olafsdottir, Olof Birna
    Hardarson, Sveinn Hakon
    Stefansson, Einar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)